Literature DB >> 26139024

Biomarkers for Alzheimer's disease: a controversial topic.

Giovanni B Frisoni1, Pieter Jelle Visser2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26139024     DOI： 10.1016/S1474-4422(15)00150-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

Review 1.  Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.

Authors:  Elvira Valera; Brian Spencer; Eliezer Masliah
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 2.  Recent Progress in the Pharmacotherapy of Alzheimer's Disease.

Authors:  Rita Khoury; Kush Patel; Jake Gold; Stephanie Hinds; George T Grossberg
Journal:  Drugs Aging       Date:  2017-11       Impact factor: 3.923

3.  Ligustilide improves aging-induced memory deficit by regulating mitochondrial related inflammation in SAMP8 mice.

Authors:  Wen-Li Zhu; Jia-Yi Zheng; Wei-Wu Cai; Zhao Dai; Ben-Yue Li; Ting-Ting Xu; Hao-Fei Liu; Xiao-Qi Liu; Su-Fen Wei; Yi Luo; Hong Wang; Hua-Feng Pan; Qi Wang; Shi-Jie Zhang
Journal:  Aging (Albany NY)       Date:  2020-02-16       Impact factor: 5.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.